Healthcare provider profile · identity verified

Joseph John Botta, MD

Geriatric Medicine · PUTNAM, CT · NPI 1831105360

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	384	72
Atorvastatin Calcium	Atorvastatin Calcium	339	77
Prednisone	Prednisone	308	130
Eliquis	Apixaban	285	48
Escitalopram Oxalate	Escitalopram Oxalate	248	49
Furosemide	Furosemide	225	58
Quetiapine Fumarate	Quetiapine Fumarate	187	26
Lorazepam	Lorazepam	184	53
Tamsulosin Hcl	Tamsulosin Hcl	183	43
Metoprolol Succinate	Metoprolol Succinate	166	41
Amlodipine Besylate	Amlodipine Besylate	164	43
Metoprolol Tartrate	Metoprolol Tartrate	163	39
Lisinopril	Lisinopril	162	43
Warfarin Sodium	Warfarin Sodium	159	11
Potassium Chloride	Potassium Chloride	155	42
Tramadol Hcl	Tramadol Hcl	153	44
Sertraline Hcl	Sertraline Hcl	139	20
Trazodone Hcl	Trazodone Hcl	137	33
Omeprazole	Omeprazole	124	45
Pantoprazole Sodium	Pantoprazole Sodium	124	38
Gabapentin	Gabapentin	111	26
Metformin Hcl	Metformin Hcl	102	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	101	16
Celecoxib	Celecoxib	92	22
Losartan Potassium	Losartan Potassium	92	26
Levetiracetam	Levetiracetam	90	suppressed
Xarelto	Rivaroxaban	90	14
Allopurinol	Allopurinol	88	17
Paroxetine Hcl	Paroxetine Hcl	86	17
Oxycodone Hcl	Oxycodone Hcl	80	13
Carvedilol	Carvedilol	79	16
Mirtazapine	Mirtazapine	78	17
Bupropion Xl	Bupropion Hcl	75	15
Rosuvastatin Calcium	Rosuvastatin Calcium	74	22
Hydrochlorothiazide	Hydrochlorothiazide	73	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	72	53
Azithromycin	Azithromycin	71	56
Famotidine	Famotidine	70	18
Olmesartan Medoxomil	Olmesartan Medoxomil	69	12
Montelukast Sodium	Montelukast Sodium	68	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	68	41
Clopidogrel	Clopidogrel Bisulfate	67	19
Glipizide	Glipizide	64	suppressed
Alprazolam	Alprazolam	63	18
Divalproex Sodium	Divalproex Sodium	59	suppressed
Amoxicillin	Amoxicillin	58	31
Carbidopa-Levodopa	Carbidopa/Levodopa	58	suppressed
Olanzapine	Olanzapine	54	11
Spironolactone	Spironolactone	53	16
Finasteride	Finasteride	51	suppressed
Clonazepam	Clonazepam	50	suppressed
Duloxetine Hcl	Duloxetine Hcl	49	14
Ozempic	Semaglutide	49	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	47	27
Atenolol	Atenolol	46	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	46	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	16
Ipratropium Bromide	Ipratropium Bromide	45	14
Labetalol Hcl	Labetalol Hcl	45	suppressed
Nystatin	Nystatin	45	30
Levofloxacin	Levofloxacin	40	19
Repatha Sureclick	Evolocumab	40	suppressed
Jardiance	Empagliflozin	39	suppressed
Rivastigmine	Rivastigmine	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	11
Venlafaxine Hcl Er	Venlafaxine Hcl	37	12
Ondansetron Odt	Ondansetron	36	22
Memantine Hcl	Memantine Hcl	35	suppressed
Methenamine Hippurate	Methenamine Hippurate	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	33	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	31	16
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Metformin Hcl Er	Metformin Hcl	31	suppressed
Simvastatin	Simvastatin	31	suppressed
Bumetanide	Bumetanide	30	suppressed
Prazosin Hcl	Prazosin Hcl	30	suppressed
Sotalol	Sotalol Hcl	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	15
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Bupropion Hcl	Bupropion Hcl	25	suppressed
Lactulose	Lactulose	25	suppressed
Mounjaro	Tirzepatide	25	suppressed
Risperidone	Risperidone	25	suppressed
Torsemide	Torsemide	25	suppressed
Cephalexin	Cephalexin	24	15
Donepezil Hcl	Donepezil Hcl	24	suppressed
Perphenazine	Perphenazine	24	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Midodrine Hcl	Midodrine Hcl	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Valsartan	Valsartan	21	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	20	13
Klor-Con M20	Potassium Chloride	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	11
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Calcitriol	Calcitriol	17	suppressed
Lithium Carbonate	Lithium Carbonate	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Albuterol Sulfate	Albuterol Sulfate	16	16
Fluconazole	Fluconazole	16	12
Lamotrigine	Lamotrigine	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	15	suppressed
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Pentips Pen Needle	Pen Needle, Diabetic	14	suppressed
Risperdal Consta	Risperidone Microspheres	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Cefuroxime	Cefuroxime Axetil	13	11
Clindamycin Hcl	Clindamycin Hcl	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Elmiron	Pentosan Polysulfate Sodium	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Metronidazole	Metronidazole	13	11
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Acitretin	Acitretin	12	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Estradiol	Estradiol	12	suppressed
Humalog	Insulin Lispro	12	suppressed
Novolin N	Insulin Nph Human Isophane	12	suppressed
Orphenadrine Citrate Er	Orphenadrine Citrate	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Colchicine	Colchicine	11	suppressed
Digoxin	Digoxin	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Letrozole	Letrozole	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	11	suppressed
Tafluprost	Tafluprost/Pf	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error